Morgan Stanley Maintains Equal-Weight on Abbott Laboratories, Raises Price Target to $117

Benzinga · 10/17 11:27
Morgan Stanley analyst David Lewis maintains Abbott Laboratories (NYSE:ABT) with a Equal-Weight and raises the price target from $107 to $117.